angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and alkenes

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with alkenes in 1 studies

Compound Research Comparison

Studies (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)	Trials (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)	Recent Studies (post-2010) (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)	Studies (alkenes)	Trials (alkenes)	Recent Studies (post-2010) (alkenes)
311	5	64	10,589	26	5,109

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, H; Demaegdt, H; Erdelyi, M; Hallberg, A; Hallberg, M; Johnsson, A; Karlen, A; Lindeberg, G; Vauquelin, G	1

Other Studies

1 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and alkenes

Article	Year
Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis. Journal of medicinal chemistry, 2011, Jun-09, Volume: 54, Issue:11 Topics: Alkenes; Angiotensin II; Animals; CHO Cells; Cricetinae; Cricetulus; Cystinyl Aminopeptidase; Drug Design; Drug Stability; Lactams; Nootropic Agents; Phenylacetates; Protease Inhibitors; Structure-Activity Relationship	2011

Article

Year

Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis.

Journal of medicinal chemistry, 2011, Jun-09, Volume: 54, Issue:11

Topics: Alkenes; Angiotensin II; Animals; CHO Cells; Cricetinae; Cricetulus; Cystinyl Aminopeptidase; Drug Design; Drug Stability; Lactams; Nootropic Agents; Phenylacetates; Protease Inhibitors; Structure-Activity Relationship

2011